News
11-04-2010, 04:32 AM
AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced updated financial guidance and third quarter financial results, as well as recent developments.
More... (http://www.news-medical.net/news/20101104/AVEO-third-quarter-total-collaboration-revenues-increase-to-2462-million.aspx)
More... (http://www.news-medical.net/news/20101104/AVEO-third-quarter-total-collaboration-revenues-increase-to-2462-million.aspx)